Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa, Kiran Sapkota
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107426-107426
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

The role of gamma oscillations in central nervous system diseases: Mechanism and treatment
Ao Guan, Shaoshuang Wang, Ailing Huang, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 76
Transport mechanism and pharmacology of the human GlyT1
Yiqing Wei, Renjie Li, Yufei Meng, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1719-1732.e14
Closed Access | Times Cited: 16
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
Alexander Murray, Jack C. Rogers, Mohammad Zia Ul Haq Katshu, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 81
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
Michel Cuénod, Pascal Steullet, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 4, pp. 1886-1897
Open Access | Times Cited: 78
GluD1 is a signal transduction device disguised as an ionotropic receptor
Jinye Dai, Christopher Patzke, Kifayathullah Liakath‐Ali, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 261-265
Open Access | Times Cited: 63
Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derivedNRXN1-mutant neurons
ChangHui Pak, Tamás Dankó, Vincent R. Mirabella, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 22
Open Access | Times Cited: 58
Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process
Pravat K. Mandal, Shradha Gaur, Rimil Guha Roy, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 19, pp. 2784-2802
Closed Access | Times Cited: 44
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 32
Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice
Zohreh Farsi, Ally Nicolella, Sean Simmons, et al.
Neuron (2023) Vol. 111, Iss. 21, pp. 3378-3396.e9
Open Access | Times Cited: 32
Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids
Rebecca Sebastian, Kang Jin, Narciso Pavon, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Molecular mechanisms of schizophrenia: Insights from human genetics
Zohreh Farsi, Morgan Sheng
Current Opinion in Neurobiology (2023) Vol. 81, pp. 102731-102731
Open Access | Times Cited: 24
Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them – A scoping review of available literature
Leonor Miranda
Brain Research (2024) Vol. 1846, pp. 149226-149226
Open Access | Times Cited: 12
New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 8
Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs
Tsung‐Han Chou, Hyunook Kang, Noriko Simorowski, et al.
Molecular Cell (2022) Vol. 82, Iss. 23, pp. 4548-4563.e4
Open Access | Times Cited: 30
Ion flux-independent NMDA receptor signaling
Deborah K. Park, Ivar S. Stein, Karen Zito
Neuropharmacology (2022) Vol. 210, pp. 109019-109019
Open Access | Times Cited: 29
Promising Application of D-Amino Acids toward Clinical Therapy
Yoahpoing Shi, Zahid Hussain, Yufen Zhao
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10794-10794
Open Access | Times Cited: 29
The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia
Agnieszka Matuszewska, Krzysztof Kowalski, Paulina Jawień, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6492-6492
Open Access | Times Cited: 17
The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China
Hehua Li, Yuanyuan Huang, Liqin Liang, et al.
Schizophrenia Research (2024) Vol. 267, pp. 444-450
Closed Access | Times Cited: 7
Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms
Dabing Li, Qiangwen Pan, Yewei Xiao, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Hippocampal circuit dysfunction in psychosis
Samuel Knight, Robert A. McCutcheon, Daniella Dwir, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
Célia Seillier, Flavie Lesept, Olivier Toutirais, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10336-10336
Open Access | Times Cited: 23
Abnormal synaptic plasticity and impaired cognition in schizophrenia
Xiulin Wu, Qiujin Yan, Fan Zhu
World Journal of Psychiatry (2022) Vol. 12, Iss. 4, pp. 541-557
Open Access | Times Cited: 22
GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
Amany Digal Ladagu, Funmilayo Eniola Olopade, Adeboye Adejare, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1535-1535
Open Access | Times Cited: 13
The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking
Rhushikesh A. Phadke, Alison Brack, Luke A. Fournier, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 5
Electroretinographic dysfunction, insulin resistance, and childhood trauma in early-course psychosis: A case-control exploratory study
Erik Velez-Perez, Nicolas Raymond, Chelsea Kiely, et al.
Biomarkers in Neuropsychiatry (2024) Vol. 10, pp. 100088-100088
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top